Energy COVID-19 collapse: new diagnostic markers, treatment aspects

Саливончик Д.П, Саливончик Е.И

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali · 2021-yil

Annotatsiya

An independent diagnostic criterion for assessing the prognosis in patients with COVID-19 is the dynamics of lactate levels, the overproduction of which is due to the crisis of energy-producing systems and an overload of the glycolytic pathway of energy production. The only corrector for the energy collapse caused by COVID-19 is the use of thiotriazoline, a metabolic drug with multiple pathways for lactate utilization and stimulation of oxidative phosphorylation, with powerful antioxidant properties. Such drugs as blockers of fatty acid metabolism (trimetazidine, meldonium) in this situation have no pathogenetic and biochemical substantiation.

Maqola ma’lumotlari
MualliflarСаливончик Д.П, Саливончик Е.И
JurnalJournal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali
NashriyotСамарқанд давлат тиббиёт университети
Nashr sanasi2021-07-23
Jild2
Son2
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-26

Kalit so‘zlar

COVID-19, гиперпродукция лактата, энергетический коллапс, Тиотриазолин, COVID-19, lactate overproduction, energy collapse, thiotriazoline, COVID-19, laktatning ortiqcha ishlab chiqarilishi, energiya kollapsi, Tiotriazolin

Ilmiy soha

Iqtibos keltirish

APAСаливончик Д.П, & Саливончик Е.И (2021). ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS. Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 2(2). https://www.tadqiqot.uz/index.php/cardio/article/view/1918
GOST (OAK)Саливончик Д.П, Саливончик Е.И ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS // Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali. – 2021. – T. 2, № 2.
MLAСаливончик Д.П, and Саливончик Е.И. “ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS.” Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 2(2), 2021. https://www.tadqiqot.uz/index.php/cardio/article/view/1918
ChicagoСаливончик Д.П, and Саливончик Е.И. “ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS.” Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 2(2) (2021). https://www.tadqiqot.uz/index.php/cardio/article/view/1918
HarvardСаливончик Д.П, and Саливончик Е.И (2021) ‘ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS’, Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 2(2). https://www.tadqiqot.uz/index.php/cardio/article/view/1918
BibTeX
@article{article2021,
  title = {ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS},
  author = {Саливончик Д.П and Саливончик Е.И},
  journal = {Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali},
  year = {2021},
  volume = {2},
  number = {2},
  url = {https://www.tadqiqot.uz/index.php/cardio/article/view/1918}
}

Boshqa maqola uchun iqtibos tayyorlash

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali jurnalidan boshqa maqolalar

Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar · 2021-yil arxivi

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari